Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Siddiq, Samreen ^b   Pamphilon, Derwood ^a   Brunskill, Susan ^a   Doree, Carolyn ^a   Hyde, Chris ^a   Stanworth, Simon ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

*Bone marrow cells; *Tissue donors psychology ; Anxiety etiology ; Granulocyte colony stimulating factor administration dosage ; Hematopoietic stem cell mobilization adverse effects ; Hematopoietic stem cells; Humans; Pain, postoperative *etiology ; Randomized controlled trials as topic; Tissue and organ harvesting *adverse effects; methods; mortality

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; ANEMIA; ANKYLOSING SPONDYLITIS; ANOREXIA; ANXIETY; ARTHRALGIA; ASPERGILLOSIS; BACKACHE; BLEEDING; BLOOD TRANSFUSION; BONE MARROW CELL; BONE PAIN; CHILL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION LOSS; DEEP VEIN THROMBOSIS; DIZZINESS; DRUG FATALITY; DYSPNEA; FATIGUE; FEVER; GRAFT VERSUS HOST REACTION; HEADACHE; HEART PALPITATION; HEMATOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOTENSION; INJECTION SITE PAIN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA; LOW BACK PAIN; METHODOLOGY; MORBIDITY; MORTALITY; MUSCULOSKELETAL PAIN; MYALGIA; MYELODYSPLASTIC SYNDROME; NAUSEA; ODYNOPHAGIA; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHLEBITIS; PRURITUS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REVIEW; RIGIDITY; RISK; SICKLE CELL CRISIS; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SORE THROAT; SPLEEN RUPTURE; SYNCOPE; THORAX PAIN; THROMBOCYTOPENIA; TINNITUS; TREATMENT DURATION; ULCERATIVE COLITIS; VOMITING; WALKING DIFFICULTY; WEAKNESS;

EID: 70249114400     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006406.pub2     Document Type: Review

References (40)

1. Bredeson C, Leger C, Couhan S, Simpson D, Huebsch L, Walker I, et al. An evaluation of the donor experience in the Canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biology of Bone and Marrow Transplantation 2004;10:405-414 (Pubitemid 38647289)
2. Favre G, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplantation 2003;32(9):873-880 (Pubitemid 37369264)
3. Fortanier C, Kuentz M, Sutton L, Milpied N, Michalet M, Macquart-Moulin G, et al. Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study. Bone Marrow Transplantation 2002;29:145-149 (Pubitemid 34144847)
4. Heldal D, Brinch L, Tjonnfjord G, Solheim BG, Egeland T, Gadeholt G, et al. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints. Bone Marrow Transplantation 2002;29:479-486 (Pubitemid 34428715)
5. Kennedy GA, Morton J, Western R, Butler J, Daly J, Durrant S. Impact of stem cell donation modality on normal donor quality of life: a prospective randomised study. Bone Marrow Transplantation 2003;31:1033-1035 (Pubitemid 36722417)
6. Rowley SD, Donaldson G, Lilleby K, Bensinger WI, Applebaum FR. Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation. Blood 2001;97(9):2541-2548
7. Beyer J, Schwella N, Stroscheer I, Schwaner I. Randomised comparison of haemopoietic rescue with stem/progenitor cells from bone marrow or peripheral blood after high-dose chemotherapy in germ cell tumors. Bone Marrow Transplantation 1994;14(Supplement 1):S45. (Pubitemid 24288651)
8. Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, et al. Bone marrow versus peripheral blood stem cells as rescue after high-dose chemotherapy. Blood 1993;82:454a.
9. Clark R. Protocol for the collection and transplantation of peripheral blood stem cells from unrelated donors. National Research Register - N0207073104.
10. Ho AD, Young D, Maruyama M, Law P, Corringham ET, Mason JR. Mobilization and purification of CD34+ cells from normal donors - regimens with G-CSF, GM-CSF, or a combination of both. Bone Marrow Transplantation 1996;17(Suppl 2):S34-S37. (Pubitemid 26125734)
11. * Hutchinson R. Phase II randomised, multicentre trial comparing the safety and feasability of allogeneic filgrastim-mobilised peripheral blood progenitor cell transplantation (PBPCT) with allogeneic bone marrow transplantation (BMT). National Research Register Document - N0123090369 1997.
12. Karlsson L, Quinlan D, Guo D, Brown C, Selinger S, Klassen J, et al. Mobilised blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue. Bone Marrow Transplantation 2004;33(7):709-713 (Pubitemid 38499924)
13. * Kulkarni S, Singhal S, Powles R, Neville F, Shaw K, Antrum J, et al. Donor preference assessment regarding bone marrow (BM) versus lenograstim mobilized peripheral stem cells (PBSC) for allograft. Blood 1998;92(10 Suppl 1 (Pt1)):141a.
14. Lorigan P. The use of unrelated donors for the collection of peripheral blood stem cell for transplantation. National Research Register - N0276081490 2000.
15. * Rogers J. Allogeneic PBSCT - the implications for donors. Bone Marrow Transplant 1996;17:S156.
16. Singhal S, Powles R, Treleaven J, Long S, Rowland A, Mehta J. Harvesting both marrow and G-CSF mobilised blood stem cells within a week in healthy donors: clinical and haematologic consequences. British Journal of Haematology 1996;93(Suppl 2):258.
17. Switzer GE, Goycoolea JM, Dew MA, Graeff EC, Hegland J. Donating stimulated peripheral blood stem cells vs bone marrow: Do donors experience the procedures differently?. Bone Marrow Transplantation 2001;27(9):917-923 (Pubitemid 32529872)
18. Arshad M, Seiter K, Bilaniuk J, Qureshi A, Patil A, Ramaswamy G, et al. Side effects related to cancer treatment: CASE 2. Splenic rupture following pegfilgrastim. Journal of Clinical Oncology 2005;23(33):8533-8534 (Pubitemid 46260251)
19. Balaguer H, Galmes A, Ventayol G, Bargay J, Besalduch J. Splenic rupture after granulocyte colony-stimulating factor mobilisation in a peripheral blood progenitor cell donor. Transfusion 2004;44(8):1260-1261 (Pubitemid 38989764)
20. Bennett CL, Evens AM, Andristos LA, Balasubramanian L, Mai M, Fisher MJ, et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. British Journal of Haematology 2006;135(5):651-652 (Pubitemid 44674074)
21. Brown SL, Dale DC. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurence in an allogeneic donor of peripheral blood stemcells. Biology of Blood and Marrow Transplantation 1997;3(6):341-343
22. Buckner CD, Clift RA, Sanders JE, Stewart P, Bensinger WI, Doney KC. Marrow harvesting from normal donors. Blood 1984;64(3):630-634
23. Dincer AP, Gottschall J, Margolis DA. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilisation. Journal of Paediatric Haematology and Oncology 2004;26(11):761-763 (Pubitemid 39577727)
24. Falzetti F, Aversa F, Minelli O, Tabillio A. Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a healthy donor. Lancet 1999;353(9152):555. (Pubitemid 29078428)
25. Goldman JM, Madrigal JA, Pamphilon D. Possible harmful effects of short course granulocyte-colony-stimulating factor in normal donors. British Journal of Haematology 2006;135(5):651-652 (Pubitemid 44674075)
26. Gratwohl A, Baldomero HK, Frauendorfer K, Urbano-Ispizua, Niederweiser D. Results of the EBMT activity survey 2005 on haemopoietic stem cell transplantation focus on increasing use of unrelated donors for the Joint Accreditation Committee of the International Society for Cellular Therapy: ISCT and the European Group for Blood and Marrow Transplantation: EBMT (JACIE). Bone Marrow Transplantation 2007;39:71-87.
27. Hasenclever D, Sextro M. Safety of AlloPBPCT donors: biometrical considerations on monitoring long-term risks. Bone Marrow Transplantation 1996;17(Suppl 2):S28-30. (Pubitemid 26125732)
28. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Review of Interventions [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester: John Wiley & Sons Ltd, 2006.
29. Jüni P, Altman DG, Egger M. Systematic Reviews in Health Care: assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-46 (Pubitemid 32682008)
30. Kasper C, Jones L, Fujita Y, Morgenstern GR, Scarffe JH, Chang J. Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation. Annals of Haematology 1999;78(2):91-92 (Pubitemid 29132442)
31. Kuendgen A, Fenk R, Bruns I, Dommach M, Schutte A, Engers R, et al. Splenic rupture following administration of pegfilgrastim in a patient with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation 2006;38(1):69-70. (Pubitemid 43923092)
32. Nishimori M, Yamada Y, Hoshi K, Akiyama Y, Hoshi Y, Morishima Y. Health related quality of life of unrelated bone marrow donors in Japan. Blood 2002;99(6):1995-2000. (Pubitemid 34525480)
33. Nuamah NM, Goker H, Kilic YA, Dagmoura H, Cakmak A. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (G-CSF). A case report and review of the literature. Haematologica 2006;91(Suppl 5):ECR08.
34. O'Malley DP, Whalen M, Banks PM. Spontaneous splenic rupture with fatal outcome following G-CSF administration for myelodysplastic syndrome. American Journal of Haematology 2003;73(4):294-295 (Pubitemid 36898891)
35. Pamphilon D, Nacheva E, Navarette C, Madrigal A, Goldman J. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors. Transfusion 2008;48(7):1495-1501.
36. The Cochrane Collaboration. Review Manager (Rev Man). 5.0. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
37. Switzer GE, Goycoolea JM, Dew MA, Graeff EC, Hegland J. Donating stimulated peripheral blood stem cells vs. bone marrow: do donors experience the procedures differently?. Bone Marrow Transplantation 2001;27(9):917-923 (Pubitemid 32529872)
38. Veerappan R, Morrison M, Williams S, Variakojis D. Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation: review of the literature. Bone Marrow Transplant 2007;40(4):361-364 (Pubitemid 47207747)
39. Watring NJ, Wagner TW, Stark JJ. Spontaneous splenic rupture secondary to pegfilgrastim to prevent neutropenia in a patient with non-small cell lung carcinoma. American Journal of Emergency Medicine 2007;25(2):247-248
40. Bone marrow donors worldwide. http://www.bmdw.org/.